« Back
Home /
Moxifloxacin

Moxifloxacin

Item no.	HY-66011A-500mg
Manufacturer	MedChem Express
CASRN	151096-09-2
Amount	500 mg
Quantity options	100 mg 1 g 500 mg 50 mg
Category	Food Safety Antibiotics Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.72
Citations	[1]Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88.\|[2]Balfour JA, et al. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000 Jan;59(1):115-39.\|[3]Grayo S, et al. Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes. Antimicrob Agents Chemother. 2008 May;52(5):1697-702.\|[4]Ioannidis O, et al. Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia. Microbiol Immunol. 2014 Feb;58(2):96-102. ACS Chem Biol. 2021 Dec 15.\|Antibiotics (Basel). 2022, 11(2), 192.\|Antimicrob Agents Chemother. 2024 Oct 29:e0094524.\|Antimicrob Agents Chemother. 2024 Oct 29:e0105124.\|bioRxiv. 2024 Nov 06.\|Infect Drug Resist. 2021 Sep 14;14:3729-3736.\|Molecules. 2025 Mar 9;30(6):1224.\|Nat Commun. 2022 Mar 2;13(1):1116.\|Nat Microbiol. 2023 Mar;8(3):410-423.\|Cell Mol Life Sci. 2022 Jul 22;79(8):441.\|Universität zu Lübeck. Klinik für Dermatologie, Allergologie und Venerologie.
Smiles	O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC)C1=O)O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BAY 12-8039 (free base)
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Antibiotic; Bacterial
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	401.43
Product Description	Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2].
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO: 31.25 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturer - Pathway	Anti-infection
Isoform	Quinolone
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-66011A-500mg-safety-datasheet.pdf